이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Efficacy of Automated Tuina and Acupuncture for Treating Chronic Lower Back Pain

2026년 11월 15일 업데이트: Linda Zhong, Nanyang Technological University

Efficacy of Automated Tuina and Acupuncture for Treating Chronic Lower Back Pain: a Randomized Controlled Study

The goal of this clinical trial is to learn if adding automated robotic Tuina to acupuncture yields a better outcome than acupuncture alone in treating adults with chronic nonspecific low back pain. It will also learn about the safety of the automated robotic Tuina. The main questions it aims to answer are:

Does robotic Tuina and acupuncture reduces score of Visual Analogue Scale (VAS) more than acupuncture alone? Does it improve the sleep, quality of life, pain related impact of participants? Researchers will compare automated robotic Tuina and acupuncture to acupuncture alone if the combination works better to treat chronic nonspecific low back pain.

Participants will:

Receive weekly treatment of either automated robotic Tuina and acupuncture or acupuncture only for 6 sessions over 8 weeks.

Visit the clinic weekly for interventions and test. Wear a sleep tracker ring on the night before and night of treatment to sleep.

연구 개요

상태

모병

정황

개입 / 치료

상세 설명

Chronic nonspecific low back pain is a common condition that can affect daily activities and quality of life. Tuina is a traditional Chinese medicine manual therapy that may help relieve pain and improve function. Automated robotic Tuina may offer a more standardized approach to delivering this treatment.

This randomized controlled study aims to evaluate whether adding automated robotic Tuina to acupuncture provides additional benefits for adults with chronic nonspecific low back pain, compared with acupuncture alone.

A total of 56 participants aged 21 to 70 years are planned for recruitment across three study sites in Singapore. Participants will be randomly assigned in a 1:1 ratio to receive either acupuncture alone or acupuncture combined with automated robotic Tuina.

The primary outcome is low back pain intensity measured using a visual analogue scale (VAS). Secondary outcomes include physical disability, pain-related interference, quality of life, sleep-related measures and acceptance of robotic Tuina. Adverse events will also be monitored throughout the study.

The findings may help clarify the additional clinical benefit and safety of automated robotic Tuina when used alongside acupuncture for chronic nonspecific low back pain.

연구 유형

중재적

등록 (추정된)

56

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

      • Singapore, 싱가포르, 229469
        • 모병
        • Novahealth TCM Clinic
        • 연락하다:
          • Chin Ee Ho
          • 전화번호: +65 84130628
      • Singapore, 싱가포르, 637551

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

21년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Adults aged 21 to 70 years.
  • At least one primary care visit for back pain within the past 3 to 12 months at either a Chinese medicine or Western medicine clinic.
  • Non-specific, uncomplicated low back pain, as specified in the study protocol.
  • Able to communicate and write in English and/or Chinese.

Exclusion Criteria:

  • Previous acupuncture for back pain within the past 3 months.
  • Low back pain lasting less than 3 months.
  • Mild symptoms, defined in the protocol as a score below 5 on a 0 to 10 pain bothersomeness scale.
  • Specific diseases or pathologies identified as the cause of back pain, including the conditions listed in the study protocol.
  • Previous vertebral column or back surgery.
  • Disabling chronic conditions that may confound treatment effects or interpretation of the data.
  • Contraindications to acupuncture or situations in which its safety has not been confirmed, including clotting disorders, anticoagulant therapy, a cardiac pacemaker, pregnancy or seizure disorder.
  • Deemed unfit for acupuncture and/or robotic Tuina by the treating Chinese medicine physician because of the participant's current medical condition.
  • Current use of long-term medication for pain management and relief, as specified in the study protocol.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Acupuncture Plus Automated Robotic Tuina

Standard acupuncture treatment followed by Automated Robotic Tuina

Participants receive 30 minute standard acupuncture and automated robotic Tuina using the EMMA device, according to the study's standardized operating procedures. Robotic Tuina is applied to the lumbosacral region, hips and lower limbs. The protocol describes an approximately 30-minute robotic Tuina treatment, with the applied force adjusted according to participant feedback within the specified range.

활성 비교기: Acupuncture alone

Standard acupuncture

Participants receive acupuncture according to the study's standardized treatment protocol. The protocol describes needle retention for 30 minutes and specifies the acupuncture points and procedures to be used.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Change from baseline in pain intensity. Visual analogue scale.
기간: At baseline, at 8 weeks

A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain

At baseline, at 8 weeks

2차 결과 측정

결과 측정
측정값 설명
기간
Change from baseline in Roland Morris Disability Questionnaire (RMDQ).
기간: At baseline and at 8 weeks

This is a self-reported questionnaire consisting in 24 items reflecting limitations in different activities of daily living attributed to low back pain including walking, vending over, sitting, lying down, dressing, sleeping, self-care and daily activities.

At baseline and at 8 weeks
Change from baseline in Brief Pain Inventory (BPI)
기간: At baseline and at 8 weeks

Pain interference was evaluated using the Pain Interference subscale of the Brief Pain Inventory (BPI). The subscale consists of 7 items assessing how much pain disrupts dimensions of daily living. Each item is scored on a 0 to 10 numeric rating scale. The overall score is calculated as the mean of the 7 items, yielding a final score ranging from a minimum of 0 to a maximum of 10. A higher score indicates a worse outcome (greater pain interference with daily functioning).

At baseline and at 8 weeks
Change from baseline in WHO-QOL (Brief)
기간: At baseline and at 8 weeks

Quality of life was evaluated using the World Health Organization Quality of Life-BREF (WHOQOL-BREF). The scale comprises 26 items assessing 4 domains: Physical Health (7 items), Psychological (6 items), Social Relationships (3 items), and Environment (8 items). Domain scores are calculated by summing the respective items and converting them to a transformed scale. For each domain, scores range from a minimum of 0 to a maximum of 100, where a higher score indicates a better outcome (higher quality of life)

At baseline and at 8 weeks
Change in objective sleep parameters via wearable smart ring
기간: At baseline throughout the 8 weeks, to be tracked the night before and after treatment session.

Assessed using Leadtek smart ring worn on the finger. Evaluated parameters include sleep time, overnight heart rate variability and sleep quality from baseline to week 8

At baseline throughout the 8 weeks, to be tracked the night before and after treatment session.
Change in Technology Acceptance Model (TAM) questionnaire from baseline
기간: At baseline and at 8 weeks

Participant acceptance of automated robotic Tuina, will be measured at baseline and after completion of study covering domains including perceieved usefulness, attitude and behavioural intentions. A 7-point Likert scale was used to measure TAM constructs, where 1 indicated 'strongly disagree' and 7 indicated ' strongly agree'. A higher score reflects better perception of and attitutude towards the technology.

At baseline and at 8 weeks
Incidence of Treatment-Emergent Adverse Events [Safety]
기간: From start of treatment to end of treatment at week 8

Incidence and nature of adverse events during the study.

From start of treatment to end of treatment at week 8

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

협력자

수사관

  • 수석 연구원: Linda Zhong, Associate Professor, Nanyang Technological University

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 1월 1일

기본 완료 (추정된)

2027년 12월 30일

연구 완료 (추정된)

2027년 12월 30일

연구 등록 날짜

최초 제출

2026년 10월 29일

QC 기준을 충족하는 최초 제출

2026년 11월 15일

처음 게시됨 (실제)

2026년 11월 18일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 18일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 15일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

추가 관련 MeSH 약관

기타 연구 ID 번호

  • IRB-2023-1071

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

IPD 계획 설명

Individual participant data will not be made available to external researchers. Participant-level data contain confidential health information and will be managed in accordance with the approved study protocol, informed consent requirements, institutional policies and applicable data-protection requirements. Study findings will be disseminated through appropriate scientific publications and other research outputs.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .